Skip to main content
. 2024 Apr 22;8(4):e13069. doi: 10.1002/jgh3.13069

Figure 1.

Figure 1

Flowchart of patient enrollment. In total, 124 patients were randomized and treated with either VAM triple therapy or VAC triple therapy. Five patients dropped out or interrupted their therapy. VAC triple therapy: vonoprazan + amoxicillin + clarithromycin 1‐week eradication therapy; VAM triple therapy: vonoprazan + amoxicillin + metronidazole 1‐week eradication therapy.